Stay updated on IpilimumabNivolumabLeptoMetClinicalTrial
Sign up to get notified when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.

Latest updates to the IpilimumabNivolumabLeptoMetClinicalTrial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a technical label change and does not modify study content, eligibility criteria, or results.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe label 'Last Update Posted (Estimated)' was replaced with 'Last Update Posted' for the study record's update timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a dedicated Locations section detailing Massachusetts-based study sites (e.g., Boston; Massachusetts General Hospital). Removed the Massachusetts Locations entry and the HHS Vulnerability Disclosure from the footer; page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to IpilimumabNivolumabLeptoMetClinicalTrial
Enter your email address, and we'll notify you when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.